Navigation Links
European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
Date:12/21/2009

ed, may not provide numerous benefits to CTI (including, regulatory assistance, reduced regulatory fees associated with applying for marketing approval, or assistance with clinical trial design), CTI's ability to continue to raise capital as needed to fund its operations, competitive factors, technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise


    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    E: deramian@ctiseattle.com
    www.CellTherapeutics.com/media.htm

    Investors Contact:
    Ed Bell
    T: 206.282.7100
    Lindsey Jesch
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.CellTherapeutics.com/investors

    Medical Information Contact:
    T: 800.715.0944
    E: info@askarm.com

SOURCE Cell Therapeutics, Inc.


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer
2. European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient
3. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
4. Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8
5. Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
6. Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
7. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
8. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
9. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
10. BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries
11. Solta Medical Announces New Fraxel re:store(R) Dual Laser System, Receives CE Mark for European Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Spring ... novel therapeutics for the treatment of RNA viruses, ... Institutes of Health (NIH) for animal testing of ... viral pathogens, classified as "Special Pathogens," against which ... 9200, derived from Spring Bank,s proprietary ...
(Date:9/18/2014)... 18, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... focused on discovering, developing and commercializing innovative ... RNA-targeted technologies, today announced that the Company,s President ... Cauwenbergh , will present at the 7 ... Wednesday, September 24, 2014 at 11:20 a.m. ...
(Date:9/17/2014)... DALLAS , Sept. 17, 2014 /PRNewswire-iReach/ -- ... Methyl Methacrylate (MMA) Industry" and "2014 Market Research ... research reports to its store. Photo ... Market Research Report on Global Methyl Methacrylate (MMA) ... on China and Global ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... 18, 2014 -- Only about half of all pregnant ... leaving thousands of moms-to-be and their babies at increased risk ... should be a routine part of prenatal care," said Edward ... providers should offer their pregnant patients a flu shot each ... it." , A report by the U.S. Centers for Disease ...
(Date:9/18/2014)... German . In ... fight a pathogen tooth and nail, but rather tolerate it to ... of tolerance is that the disease only progresses very slowly ... pathogen load. , Roland Regoes, a senior scientist at ETH Zurich,s ... He set about investigating whether there are infected people who are ...
(Date:9/18/2014)... CRDF Global released today its ... edition – rich with videos, images and interactive ... Global empowers scientists and innovators around the world. ... foundation and individual supporters, CRDF Global reaches across ... training and entrepreneurship. , The Annual Report highlights ...
(Date:9/18/2014)... Africa (PRWEB) September 18, 2014 Phela ... adopt the HABIT™ Program in South Africa. ... Health and Wellness, and distributed in South Africa by ... the HABIT program, which has been tailored to address ... HABIT™ focuses on behavior modification and chronic disease prevention. ...
(Date:9/18/2014)... new expert panel report, Improving Medicines for Children ... Canadian Academies, addresses the importance of developing safe ... half of Canada,s seven million children use at ... is done off-label (i.e. the prescription differs from ... have historically been excluded in drug research and ...
Breaking Medicine News(10 mins):Health News:Flu vaccine for expectant moms a top priority 2Health News:Withdrawal from the evolutionary race 2Health News:Withdrawal from the evolutionary race 3Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2Health News:Improving medicines for children in Canada 2
... Event at Penn State Hershey to Launch 2008 ... Thousands of,Pennsylvania taxpayers who participate in the ... Research deserve recognition for the,thousands of dollars in ... year. On Monday, February 11 at 9:30 a.m., ...
... Montreal, 6 February 2008 - A recent study by ... Health Centre research Institute, sheds some new light on ... Hastons study is pointing at genetics as contributing to ... implications in changing therapeutic practices. The article was published ...
... ) announced today that its Chief Executive Officer, Mark,McAndrew, and Chief Financial Officer, ... Conference in,New York City. Torchmark,s presentation is scheduled to begin at 2:20 p.m.,EST., ... The presentation will be webcast live at:, ... http://www.torchmarkcorp.com ...
... Group on,Health (NBGH) and the Office of Minority Health ... 2008 at 1:30 p.m. EST to announce a new,initiative ... improve the quality of health care for a culturally ... and public health,together to develop guidance and strategies for ...
... Tobacco-Free Kids, WASHINGTON, Feb. 7 The World ... clear both,the devastating scope of the global tobacco epidemic ... the world today - and the fact that it ... presents the first comprehensive picture of what the world,s ...
... February 19, 9 a.m. - 5 p.m.), SCOTTSDALE, ... Children,s Dental Health Month. Dr. Lee Weinstein, a ... Associates for Kids Only, will be offering a Free ... a.m. until 5 p.m., The first 30 patients that ...
Cached Medicine News:Health News:The Pennsylvania Breast Cancer Coalition Announces 2008 Breast Cancer Income Tax Check-Off Grant Recipients 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 2Health News:Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions 3Health News:Free Children's Dental Day; Expert Source on Children's Dental Health Available 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: